搜索临床试验以:Refralon 药物复律
总计3570个结果
-
Hutchmed完全的
-
Fudan University未知
-
Organon and CoMerck Sharp & Dohme LLC; Schering-Plough完全的
-
Raymond T. Chung, MDMerck Sharp & Dohme LLC撤销
-
Zhao ChongCancer Institute and Hospital, Chinese Academy of Medical Sciences; Jiangxi Provincial Cancer... 和其他合作者完全的
-
U.S. Army Medical Research and Development CommandGlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)完全的
-
Institut Claudius RegaudAdvanced Accelerator Applications招聘中
-
Fondazione Italiana Sindromi Mielodisplastiche-ETSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte完全的
-
University Hospital, Antwerp招聘中
-
Institut de cancérologie Strasbourg EuropeICube Laboratory完全的
-
Centre Hospitalier Universitaire, Amiens完全的
-
Kirby Institute完全的
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI); National Center for Advancing Translational...招聘中
-
Medical Enterprises Ltd.终止膀胱癌 | 膀胱癌 | 膀胱恶性肿瘤 | 膀胱肿瘤 | 膀胱癌 | 膀胱原位癌 | 膀胱肿瘤 | 膀胱癌 | 肿瘤,膀胱 | 膀胱乳头状癌(诊断) | 卡介苗反应迟钝的膀胱癌美国
-
University of Colorado, Denver完全的
-
Jiangsu Yahong Meditech Co., Ltd aka Asieris主动,不招人
-
eMKa MED Medical CenterWroclaw Medical University招聘中
-
Women's Hospital School Of Medicine Zhejiang UniversitySun Yat-sen University; Qilu Hospital of Shandong University; Second Affiliated Hospital, School... 和其他合作者招聘中上皮性卵巢癌 III 期 | 上皮性卵巢癌 IV 期 | 输卵管癌 III 期 | 输卵管癌 IV 期 | 原发性腹膜癌 III 期 | 原发性腹膜癌 IV 期中国
-
Threshold PharmaceuticalsEMD Serono终止
-
Fudan University主动,不招人
-
John MascarenhasNational Cancer Institute (NCI); Incyte Corporation; Myeloproliferative Disorders-Research Consortium完全的